SEC Form 4 · accession 0001209191-18-062223
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dashyant Dhanak
Officer — EVP & Chief Scientific Officer
Period of report
Dec 10, 2018
Accepted (ET)
Dec 12, 2018 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 10, 2018 | A | 6,878 | $0.00 | A | 6,878 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $65.42 | Dec 10, 2018 | A | 48,403 | A | — | Dec 10, 2028 | Common Stock | 48,403 | 48,403 | D |
Explanation of responses
- F1Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Dr. Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- F2Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.